Display:
Providers:
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.
|
|
|
|
|
January 30, 2023 | ||
---|---|---|
January 18, 2023 | ||
January 17, 2023 | ||
January 09, 2023 | ||
January 05, 2023 | ||
January 04, 2023 | ||
January 03, 2023 | ||
December 21, 2022 | ||
December 20, 2022 | ||
December 19, 2022 | ||
December 16, 2022 | ||
December 15, 2022 | ||
December 14, 2022 | ||
December 13, 2022 | ||
December 08, 2022 | ||
December 07, 2022 | ||
November 29, 2022 | ||
Next > |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.